AMGN - Financial Reports List - Amgen Inc. - IntrinsicAlpha

Amgen Inc. AMGN

Healthcare - Drug Manufacturers - General - NASDAQ - US

$ 278.4

-1.3 %

$ 150 B

Market Cap

36.15

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	10.86%	-18.25%	81.83%
Annual Report	FY	10-K	2024-12-31	18.57%	-39.11%	-8.09%
Quarterly Report	Q3	8-K	2024-09-30	23.18%	63.58%	1.29%
Quarterly Report	Q2	8-K	2024-06-30	20.07%	-45.90%	-28.87%
Quarterly Report	Q1	8-K	2024-03-31	21.98%	-3.98%	-48.41%
Quarterly Report	Q4	8-K	2023-12-31	19.84%	-52.54%	1.52%
Annual Report	FY	10-K	2023-12-31	7.09%	2.52%	48.02%
Quarterly Report	Q3	8-K	2023-09-30	3.77%	-19.27%	5.10%
Quarterly Report	Q2	8-K	2023-06-30	5.94%	4.71%	23.35%
Quarterly Report	Q1	8-K	2023-03-31	-2.13%	92.48%	70.15%

1